Biotricity (OTCBB: BTCY) is a comer in the rapidly growing medical device market and is a small cap to take notice of. Driving this lucrative market are; IoT-driven device connectivity, governmental pressure to cut healthcare costs, escalating hospital costs, a need to reduce hospital readmission rates, an aging population, and a high rate of people with chronic disease. The largest factor driving this market is the rapidly growing rate of those afflicted with chronic disease.
The Center for Disease Control (CDC) cites that over 50% of all adults have at least one chronic disease. Thats one adult in two. Im feeling fine. How about you? Hopefully, youre disease free. If so, statistically, that leaves two people in America who are not. Logically, if half of our adult population suffers from chronic disease, the health of these people must be monitored. According to U.S. Census Bureau estimates, Americas adult population exceeds 250,000,000. That leaves over 125,000,000 adults who are candidates for medical monitoring.
Hot Small Cap Stocks To Buy Right Now: China Metro-Rural Holdings Limited(CNR)
- [By Shane Hupp]
Wall Street analysts expect that Canadian National Railway (NYSE:CNI) (TSE:CNR) will announce $1.02 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Seven analysts have provided estimates for Canadian National Railway’s earnings, with the highest EPS estimate coming in at $1.06 and the lowest estimate coming in at $0.97. Canadian National Railway reported earnings per share of $1.00 in the same quarter last year, which would suggest a positive year over year growth rate of 2%. The company is expected to announce its next quarterly earnings results on Tuesday, July 24th.
- [By Max Byerly]
Canadian National Railway (NYSE:CNI) (TSE:CNR) – Cormark raised their Q3 2018 earnings per share (EPS) estimates for Canadian National Railway in a research report issued to clients and investors on Tuesday, April 10th. Cormark analyst D. Tyerman now expects that the transportation company will post earnings per share of $1.15 for the quarter, up from their previous estimate of $1.14.
Hot Small Cap Stocks To Buy Right Now: FuelCell Energy Inc.(FCEL)
- [By Paul Ausick]
FuelCell Energy Inc. (NASDAQ: FCEL) posted a new 52-week low of $1.00 on Friday, down 60% compared with Thursday’s closing price of $1.60. The stock’s 52-week high is $8.88. Volume of around 12.4 million shares was about 13 times the daily average of around 800,000 shares. The company priced a secondary stock offering of 12 million shares and additional warrants at $1.28 to raise $15.4 million.
- [By Lisa Levin]
FuelCell Energy Inc (NASDAQ: FCEL) shares dropped 33 percent to $1.08. FuelCell Energy priced its $15.4 million underwritten public offering of common stock and warrants.
- [By Peter Graham]
Small cap fuel cell stockFuelCell Energy Inc (NASDAQ: FCEL) reportedQ2 2017 earnings before the market opened with shares up in premarket trading. Total revenueswere $20.4 million versus $28.6 million with the revenue components being:
- [By Peter Graham]
A long term performance chart shows Ballard Power Systemsalong with alternative energy or fuel cell stock peers like small capsFuelCell Energy Inc (NASDAQ: FCEL), Hydrogenics Corporation (NASDAQ: HYGS) and Plug Power Inc (NASDAQ: PLUG) all peaking in 2014 before falling back; but BLDP and PLUG have picked up steam earlier this year:
Hot Small Cap Stocks To Buy Right Now: Achillion Pharmaceuticals Inc.(ACHN)
- [By Ethan Ryder]
Achillion Pharmaceuticals (NASDAQ:ACHN) – Research analysts at B. Riley reduced their FY2018 EPS estimates for shares of Achillion Pharmaceuticals in a research note issued to investors on Wednesday, May 2nd. B. Riley analyst M. Kumar now anticipates that the biopharmaceutical company will earn ($0.58) per share for the year, down from their previous estimate of ($0.55). B. Riley has a “Neutral” rating and a $3.50 price objective on the stock. B. Riley also issued estimates for Achillion Pharmaceuticals’ FY2019 earnings at ($0.64) EPS, FY2020 earnings at ($0.71) EPS, FY2021 earnings at ($0.70) EPS and FY2022 earnings at ($0.84) EPS.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ben Levisohn]
We updated our annual U.S. Hep C survey in early July, in order to gauge the future for Gilead, AbbVie/Enanta Pharmaceuticals (ENTA), Merck, and J&J/Achillion Pharmaceuticals (ACHN). In conjunction with script trends, physicians indicate that the market for treatment-eligible, easily accessible Hep C patients is shrinking, but that Gilead’s share of the shrinking pie is continuing to grow. With no end to script declines in sight, we are left wondering where the Hep C will bottom…
- [By Paul Ausick]
Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) dropped about 6.9% Friday to post a new 52-week low of $2.69 after closing at $2.89 on Thursday. The 52-week high is $5.66. Volume was around 6.2 million, more than three times the daily average of around 1.9 million. The company had no specific news.
Hot Small Cap Stocks To Buy Right Now: Panera Bread Company(PNRA)
- [By WWW.THESTREET.COM]
Then there’s Panera Bread (PNRA) , a company that had lost its way. But after interviewing Panera’s CEO Ron Shaich, Cramer learned that at its new, remodeled “Panera 2.0” stores, the lines were out the door. As the rollout continued, earnings only got stronger. Never underestimate the power of a restaurant redo, Cramer concluded.
- [By Motley Fool Staff]
In this segment fromMarket Foolery, host Chris Hill is joined by Motley Fool analystDavid Kretzmann as they break down how coffee-and-pastry focused JAB Holding Company will fit a fast casual brand into its privately held portfolio. With the acquisition, the JAB is expected to give thePanera Bread(NASDAQ:PNRA)team even more autonomy than usual.
- [By Ben Levisohn]
Keurigs plight (actually, JABs) is worsening, with the K-cup market slowing to almost no growth now, and Keurig continuing to lose own brands share. Starbucks (SBUX) echoed the notion of a K-cup market slowdown at its seminar on Wednesday (and is guiding for its [consumer packaged goods, or CPG,] growth below recent trends), but it expects to increase its share of total CPG coffee to 20% from 15%. Come early February it will be a year since the closing of the Keurig deal for JAB Holdings. The pressure on JAB is more significant if we take into account the high leverage of the deal (JAB contributed one fourth of the $12Bn price tag). It is a tough predicament. On the one hand we argue that to make that deal work, they need to buy more (own) brands either from the retail channel (that can be extended to CPG: Dunkin (DNKN)? Panera (PNRA)?), or outright buy CPG brands (like the entire Kraft Heinz portfolio, and or Tata Groups Eight OClock brand). But can/how do they fund these deals? Maybe Mars and Warren Buffett (Mars is involved in office coffee with Starbucks), private equity, and or 3G can help? While this note is not about Positive-rated Mondelez, we have mentioned before a scenario where Kraft Heinz buys Mondelez and partly funds the deal by selling its own CPG coffee business (~$3Bn we say) to JAB as well as divests the Mondelez 20% plus stakes in Keurig (North America) and Jacobs Douwe Egberts (Western Europe), which together at this stage are worth ~$7-8Bn. But, yes, JAB will need deep-pocket partners and generous lenders. Net, JAB needs to do something soon.
- [By WWW.THESTREET.COM]
Cramer wanted to talk a little psychology. With its after-hours move Tuesday, Panera Bread (PNRA) is up more than 16% this week on takeover speculation. Panera is an old Action Alerts PLUS name, one the trust sold at a nice gain, too.
- [By Seth McNew]
Other companies have followed suit with great success, including PaneraBread (NASDAQ:PNRA), which has focused on improving the customer experience, including via shorter wait times. Panera 2.0 was largely successful because of the company’s focus on its digital strategy and Chipotle looks to be doing the same thing.
Hot Small Cap Stocks To Buy Right Now: Rackspace Hosting Inc(RAX)
- [By Monica Gerson]
Rackspace Hosting, Inc. (NYSE: RAX) reported better-than-expected earnings for the first quarter, but the company missed analysts’ sales estimates. Rackspace shares dropped 7.72 percent to $20.80 in the after-hours trading session.